Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-14

Clinical Trial Update: Dermal Penetration of the Titanium Dioxide in Anthelios SX SPF40 Cream [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating dermal penetration of titanium dioxide from Anthelios SX SPF40 Cream. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anthelios SX SPF40 Cream (titanium dioxide-containing sunscreen cream)

Snippet

Sponsor: Loreal USA | Conditions: Sunburn | Phase 4 | Status: COMPLETED